{"id":"https://openalex.org/W4393869293","doi":"https://doi.org/10.1017/cts.2024.40","title":"21 The Microbial Antibiogram as a Function of Testing Indication: Susceptibility Analysis of Escherichia coli from Symptomatic and Asymptomatic Bacteriuria Patients, 2020-2021","display_name":"21 The Microbial Antibiogram as a Function of Testing Indication: Susceptibility Analysis of Escherichia coli from Symptomatic and Asymptomatic Bacteriuria Patients, 2020-2021","publication_year":2024,"publication_date":"2024-04-01","ids":{"openalex":"https://openalex.org/W4393869293","doi":"https://doi.org/10.1017/cts.2024.40"},"language":"en","primary_location":{"id":"doi:10.1017/cts.2024.40","doi":"https://doi.org/10.1017/cts.2024.40","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cts.2024.40","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6A8461E2839B9706398AC46CAB2E6165/S2059866124000402a.pdf/div-class-title-21-the-microbial-antibiogram-as-a-function-of-testing-indication-susceptibility-analysis-of-escherichia-coli-from-symptomatic-and-asymptomatic-bacteriuria-patients-2020-2021-div.pdf","source":{"id":"https://openalex.org/S4210205013","display_name":"Journal of Clinical and Translational Science","issn_l":"2059-8661","issn":["2059-8661"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical and Translational Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6A8461E2839B9706398AC46CAB2E6165/S2059866124000402a.pdf/div-class-title-21-the-microbial-antibiogram-as-a-function-of-testing-indication-susceptibility-analysis-of-escherichia-coli-from-symptomatic-and-asymptomatic-bacteriuria-patients-2020-2021-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018845250","display_name":"Allison Chan","orcid":"https://orcid.org/0000-0003-4270-0358","observed_orcids":["https://orcid.org/0000-0003-4270-0358"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Chan","raw_affiliation_strings":["Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094359502","display_name":"Maddie Spradley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maddie Spradley","raw_affiliation_strings":["Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tim Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tim Williams","raw_affiliation_strings":["Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060605923","display_name":"Grace H Morales","orcid":"https://orcid.org/0000-0001-5454-9195","observed_orcids":["https://orcid.org/0000-0001-5454-9195"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace Morales","raw_affiliation_strings":["Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108406404","display_name":"Gerald Van Horn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald Van Horn","raw_affiliation_strings":["Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024255811","display_name":"Jonathan E. Schmitz","orcid":"https://orcid.org/0000-0002-2727-9078","observed_orcids":["https://orcid.org/0000-0002-2727-9078"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan E. Schmitz","raw_affiliation_strings":["Department of Urology, Vanderbilt Institute for Infection, Immunology, and Inflammation; Nashville, Tennessee 37232 USA","Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Vanderbilt Institute for Infection, Immunology, and Inflammation; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology; Nashville, Tennessee 37232 USA","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2925,"currency":"USD","value_usd":2925},"apc_paid":{"value":2925,"currency":"USD","value_usd":2925},"fwci":0.6067,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.66166305,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"8","issue":"s1","first_page":"6","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.9700000286102295},{"id":"https://openalex.org/keywords/asymptomatic-bacteriuria","display_name":"asymptomatic bacteriuria","score":0.8629999756813049},{"id":"https://openalex.org/keywords/symptomatic-urinary-tract-infection","display_name":"symptomatic urinary tract infection","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.8259999752044678},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7670000195503235},{"id":"https://openalex.org/keywords/antimicrobial-resistance-trends","display_name":"antimicrobial resistance trends","score":0.6779999732971191},{"id":"https://openalex.org/keywords/ciprofloxacin-resistance","display_name":"ciprofloxacin resistance","score":0.8859999775886536},{"id":"https://openalex.org/keywords/empirical-antibiotic-selection","display_name":"empirical antibiotic selection","score":0.847000002861023},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.7149999737739563},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.3840000033378601},{"id":"https://openalex.org/keywords/indwelling-catheter","display_name":"indwelling catheter","score":0.6859999895095825},{"id":"https://openalex.org/keywords/pregnancy","display_name":"pregnancy","score":0.32899999618530273},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.8180000185966492},{"id":"https://openalex.org/keywords/antimicrobial-resistance-surveillance","display_name":"antimicrobial resistance surveillance","score":0.35899999737739563},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility-testing","display_name":"antimicrobial susceptibility testing","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C2781212295","wikidata":"https://www.wikidata.org/wiki/Q4774539","display_name":"Antibiogram","level":4,"score":0.9036978483200073},{"id":"https://openalex.org/C2911155155","wikidata":"https://www.wikidata.org/wiki/Q632522","display_name":"Asymptomatic bacteriuria","level":4,"score":0.693657398223877},{"id":"https://openalex.org/C2776216170","wikidata":"https://www.wikidata.org/wiki/Q632522","display_name":"Bacteriuria","level":3,"score":0.5558550357818604},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5556840896606445},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.543100893497467},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.5157418847084045},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.48688140511512756},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42890533804893494},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.263038694858551},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.23658394813537598},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.18275859951972961},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.1698826253414154},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09550192952156067},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1017/cts.2024.40","doi":"https://doi.org/10.1017/cts.2024.40","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cts.2024.40","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6A8461E2839B9706398AC46CAB2E6165/S2059866124000402a.pdf/div-class-title-21-the-microbial-antibiogram-as-a-function-of-testing-indication-susceptibility-analysis-of-escherichia-coli-from-symptomatic-and-asymptomatic-bacteriuria-patients-2020-2021-div.pdf","source":{"id":"https://openalex.org/S4210205013","display_name":"Journal of Clinical and Translational Science","issn_l":"2059-8661","issn":["2059-8661"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical and Translational Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11023832","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11023832","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11023832/pdf/S2059866124000402a.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Transl Sci","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:cf15d623cccd43319b3e9c540f675e0f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cf15d623cccd43319b3e9c540f675e0f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical and Translational Science, Vol 8, Pp 6-6 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1017/cts.2024.40","doi":"https://doi.org/10.1017/cts.2024.40","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cts.2024.40","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6A8461E2839B9706398AC46CAB2E6165/S2059866124000402a.pdf/div-class-title-21-the-microbial-antibiogram-as-a-function-of-testing-indication-susceptibility-analysis-of-escherichia-coli-from-symptomatic-and-asymptomatic-bacteriuria-patients-2020-2021-div.pdf","source":{"id":"https://openalex.org/S4210205013","display_name":"Journal of Clinical and Translational Science","issn_l":"2059-8661","issn":["2059-8661"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical and Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4393869293.pdf","grobid_xml":"https://content.openalex.org/works/W4393869293.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2793303202","https://openalex.org/W4282827676","https://openalex.org/W1432372474","https://openalex.org/W2135312665","https://openalex.org/W2094673992","https://openalex.org/W4229034684","https://openalex.org/W4320918159","https://openalex.org/W4402740942","https://openalex.org/W163799427","https://openalex.org/W1973865046"],"abstract_inverted_index":{"OBJECTIVES/GOALS:":[0],"Antibiograms":[1],"are":[2],"used":[3],"to":[4,29,45,116,128,154,258,305],"guide":[5,306],"empiric":[6],"antibiotic":[7,14,31,130,158,318],"selection.":[8],"However,":[9],"it":[10],"is":[11],"unclear":[12],"if":[13],"profiles":[15,33,132],"differ":[16],"between":[17,137,166,214,263,284],"symptomatic":[18,43,138,178,184,249],"urinary":[19,35,58,242],"tract":[20,243],"infections":[21],"(UTIs)":[22],"and":[23,121,139,174,179,185,192,205,218,256],"asymptomatic":[24],"bacteriuria":[25],"(ASB).":[26],"We":[27,51,80],"aimed":[28],"compare":[30,129],"susceptibility":[32,131,294,319],"of":[34,56,144,146,198,231,253,279],"E.":[36,59,104],"coli":[37,60,105],"isolates":[38,61,254],"from":[39,62,74,107,324],"patients":[40,64,232],"with":[41,47,98,222,265],"a":[42,53,108,147,240],"UTI":[44,119],"those":[46],"ASB.":[48],"METHODS/STUDY":[49],"POPULATION:":[50],"conducted":[52,127],"cohort":[54],"study":[55],"1,140":[57],"unique":[63],"that":[65,84],"received":[66],"care":[67],"through":[68],"Vanderbilt":[69],"University":[70],"Medical":[71],"Center":[72],"(VUMC)":[73],"Nov":[75],"2020":[76],"\u2013":[77],"Jun":[78],"2021.":[79],"included":[81],"any":[82],"patient":[83],"was":[85,164,282],"seen":[86],"at":[87,94,155],"VUMC":[88],"as":[89,303],"an":[90],"inpatient,":[91,215],"outpatient":[92,219,225],"or":[93,152,161,238],"the":[95,187,248],"emergency":[96,216],"department":[97],"\u2265":[99],"105":[100],"colony":[101],"forming":[102],"units/mL":[103],"detected":[106],"clinical":[109,329],"urine":[110],"specimen.":[111],"Chart":[112],"abstractions":[113],"were":[114,126,177,190,220,234,245,261],"performed":[115],"capture":[117],"reported":[118],"symptoms":[120],"demographic":[122],"information.":[123],"Descriptive":[124],"statistics":[125],"(i.e.,":[133],"susceptible,":[134],"intermediate,":[135],"resistant)":[136],"ASB":[140,273,307],"groups.":[141,167],"The":[142,211,229,251,277],"risk":[143,278],"detection":[145,281],"multidrug-resistant":[148],"organism":[149],"(MDRO)":[150],"(intermediate,":[151],"resistant":[153,255],"least":[156],"one":[157],"in":[159,247],"three":[160],"more":[162],"classes)":[163],"assessed":[165],"RESULTS/ANTICIPATED":[168],"RESULTS:":[169],"Among":[170],"1,140,":[171],"1,018":[172],"(89%)":[173],"122":[175],"(11%)":[176],"ASB,":[180,186],"respectively.":[181],"When":[182],"comparing":[183],"median":[188],"ages":[189],"50":[191],"46.":[193],"Groups":[194],"had":[195,239],"similar":[196,221,262,283,297],"proportions":[197],"no":[199],"indwelling":[200],"catheter":[201],"(94%":[202],"v.":[203,209,227,275],"95%)":[204],"without":[206],"diabetes":[207],"(87%":[208],"88%).":[210],"collection":[212],"setting":[213],"department,":[217],"most":[223],"being":[224],"(79%":[226],"83%).":[228],"proportion":[230,252],"who":[233],"pregnant,":[235],"immuno":[236],"compromised,":[237],"structural/functional":[241],"abnormality":[244],"higher":[246,270],"group.":[250],"susceptible":[257],"tested":[259],"antibiotics":[260],"groups,":[264],"only":[266],"ciprofloxacin":[267],"showing":[268],"slightly":[269],"resistance":[271],"among":[272],"(16%":[274],"25%).":[276],"MDRO":[280],"groups":[285],"(RR:":[286],"0.858,":[287],"95%":[288],"CI:":[289],"0.64,":[290],"1.15).":[291],"DISCUSSION/SIGNIFICANCE:":[292],"Antibiotic":[293],"comparison":[295],"demonstrated":[296],"profiles,":[298],"which":[299],"suggests":[300],"antibiogram":[301],"use":[302],"appropriate":[304],"treatment.":[308],"Results":[309],"offer":[310],"insight":[311],"on":[312,320],"whether":[313],"traditional":[314],"methods":[315],"for":[316],"assessing":[317],"population-levels":[321],"could":[322],"benefit":[323],"further":[325],"refinement":[326],"by":[327],"patient-specific":[328],"parameters.":[330]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-04-04T00:00:00"}